Tirzepatide
€65.00
-
Worldwide Delivery
-
Payment
Description
Tirzepatide
Tirzepatide is a 39 amino acid peptide that activates both GIP and GLP-1 receptors. Its lipidated structure is described in relation to metabolic stability and cellular uptake.
Product specifications
Dual incretin receptor activity
Tirzepatide's receptor activity is linked to insulin secretion, slower gastric emptying and reduced appetite. Its described applications concern weight management and glucose control alongside diet and exercise, with higher affinity for GIP than GLP-1.
- Appetite and craving reduction
- Support for glycemic control
- Weight management effects
- Combined GIP and GLP-1 signalling
Usage and administration
The described profile includes once weekly subcutaneous administration with gradual dose escalation from a low starting amount. Nausea and gastrointestinal effects are given as the reason for slower adjustment; no numerical strength or administration range is supplied.
Related products and comparisons
Semaglutide provides the single agonist comparison, while Retatrutide is described as the triple receptor option.
Health and usage information
This page provides educational information about the product to help you make informed choices. It does not replace medical advice. If you have a health condition or questions about dosage, consult a sports medicine doctor or another healthcare professional.
Specification
Overview
Customer Reviews
You may also like
Reviews
There are no reviews yet.